SHOULDER INNOVATIONS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
SHOULDER INNOVATIONS, INC. (SI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.08M, a 468.95% increase year-over-year.
- SHOULDER INNOVATIONS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $726.00K, a 471.65% increase year-over-year.
- SHOULDER INNOVATIONS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $298.00K, a 25.74% increase year-over-year.
- SHOULDER INNOVATIONS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $190.00K, a 11.76% increase year-over-year.
- SHOULDER INNOVATIONS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $996.00K, a 32.10% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $754.00K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.08M 10-Q · filed 2026-08-06 | $1.81M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $726.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $996.00K 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $298.00K 10-Q · filed 2025-11-12 | $488.00K derived: sum of 2 quarters · filed 2026-08-06 | $615.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $190.00K 10-Q · filed 2026-08-06 | $317.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $127.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $754.00K 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $237.00K 10-Q · filed 2025-11-12 | $407.00K derived: sum of 2 quarters · filed 2025-11-12 | $575.00K derived: sum of 3 quarters · filed 2025-11-12 | |
| 2024-06-30 | $170.00K 10-Q · filed 2025-11-12 | $338.00K derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2024-03-31 | $168.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |